Possible Diabetes Cure Being Tested on Small Number of Patients

Johnson & Johnson has teamed up with a biotech company called ViaCyte to develop the first stem cell treatment that could lead to the cure for Type 1 diabetes.The companies have already started testing a small group of patients and if they have the same success in humans as they've seen in animals, it would amount to a cure - ending the need for patients to inject insulin and constantly monitor blood sugar levels.

Dr. Tom Donner, director of the diabetes center at Johns Hopkins University School of Medicine, told ctvnews.ca "This one is potentially the real deal. It's like making a new pancreas that makes all the hormones needed to control blood sugar."

To read more on these exciting developments, click here.